The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors
Abstract
The utility of CRISPR-Cas9 and TALENs for genome editing may be compromised by their off-target activity. We show that integrase-defective lentiviral vectors (IDLVs) can detect such off-target cleavage with a frequency as low as 1%. In the case of Cas9, we find frequent off-target sites with a one-base bulge or up to 13 mismatches between the single guide RNA (sgRNA) and its genomic target, which refines sgRNA design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One such labeling tool is called the integrase-defective lentiviral vectors (IDLV), which displays the propensity to integrate into the vicinity of DSBs (Wang et al., 2015; Kim et al., 2019).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Wang et al., 2015
In the citing paper
“The major barrier of clinical use of CRISPR/Cas9 is its off-target effects [81,82,83].”
From Viral Delivery Systems for CRISPR (2019) · cites this paper as [83]
Citations
Cites
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752
Pattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2673 · Cited by 1,487
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–441 of 441
Efficient Immune Cell Genome Engineering with Improved CRISPR Editing ToolsPreprint
Chan, W., Gottschalk, R. A., Yao, Y., Pomerantz, J. L., & Germain, R. N. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.13.947002 · Cited by 1
Specificity of CRISPR‐Cas9 Gene Editing
Selfjord, N., Madsen, A., & Akçakaya, P. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch20 · Cited by 2
Kulcsár, P. I., Tálas, A., Ligeti, Z., Tóth, E., Rakvács, Z., Végi, V. L., Krausz, S. L., Huszár, K., & Welker, E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.16.504097 · Cited by 1
Reduced Binding Activity of Vaccine Serum to Omicron Receptor-Binding DomainPreprint
Wang, T., Weng, S., Li, M., Wang, Q., Yang, Z., Wang, X., Yin, Y., Zhou, Q., Lirong, Z., Tao, F., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4074674 · Cited by 1
Engineering pentatricopeptide repeat proteins for programmable nucleic acid manipulation
Chia, T. S. (2016) · UWA Profiles and Research Repository (University of Western Australia)
Genome-wide Massive Sequencing in Embryonic Stem Cell Biology:Recent Insights and Challenges
Cheung, Y. W. A. C. (2015) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000296
Dow, E. (2015)
A systemically-delivered stem cell therapy for dry age related macular degeneration
Pay, S. L. (2017) · IUScholarWorks (Indiana University) · doi:10.7912/c2006q
Generation of knockout human iPSCs to investigate genes associated with telomere length
Shamkhi, N. (2017) · Figshare
Slaughter, C. A. (2015) · Journal of Biomolecular Techniques JBT · doi:10.7171/jbt.15-2603-005
Towards best-practice approaches for CRISPR/Cas9 gene engineeringPreprint
Campenhout, C. V., Cabochette, P., Veillard, A.-C., Laczik, M., Zelisko-Schmidt, A., Sabatel, C., Dhainaut, M., Vanhollebeke, B., Gueydan, C., & Kruys, V. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/469544
Development of Novel CRISPR-Based Methods for Transcriptional Control Over Bacterial Gene Expression
Tarasava, K. (2019) · CU Scholar (University of Colorado Boulder)
Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
Cardenas‐Diaz, F. L., Maguire, J. A., Gadue, P. J., & French, D. L. (2019) · Journal of Visualized Experiments · doi:10.3791/60085
Pharmacodynamic Evaluation: Gene Therapy
Grandchamp, N. (2020) · Springer eBooks · doi:10.1007/978-3-319-68864-0_51 · Cited by 1
dos Anjos, I. W. T., Filho, I. A. D. A., Marinho, L. V. B. V., Santos, N. V. D. M., & Cézar, N. J. B. (2020) · Brazilian Journal of Health Review · doi:10.34119/bjhrv3n5-114 · Cited by 2
CRISPR, ZFNS, and TALENS for Hemoglobinopathies an Analysis
Khare, V. (2021) · International Journal for Research in Applied Science and Engineering Technology · doi:10.22214/ijraset.2021.38924
Godbey, W. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817726-6.00014-9
Extension and Improvement of CRISPR-Based Technology
Zhang, Z., Wang, P., & Liu, J. (2022) · Springer eBooks · doi:10.1007/978-981-16-8504-0_3
Crispr-Embedding: CRISPR/Cas9 Off-Target Activity Prediction Using DNA k-Mer EmbeddingPreprint
Shatabda, S., Tahsin, A., Tasnim, Z., Chowdhury, M., Hassin, K., Meraz, G. H., & Aziz, K. F. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4071629
Faculty Opinions recommendation of DeepCRISPR: optimized CRISPR guide RNA design by deep learning.
Conboy, I. M. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733509871.793553954
(2015) · Nature Methods · doi:10.1038/nmeth.3301
Pharmacodynamic Evaluation: Gene Therapy
Grandchamp, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-56637-5_51-1
Molecular Mechanisms of Type II CRISPR ‐ Cas Systems
Karvelis, T., & Šikšnys, V. (2022) · Wiley eBooks · doi:10.1002/9781683673798.ch4
Development of new increased fidelity SpCas9 variants
Kulcsár, P. I. (2019) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10317
Krishna, Y. K. Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.13.670047
CRISPR System and AI Applications
Asim, M. N., Ahmed, S., & Dengel, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-90450-9_7
Kwon, J., Kim, M., Hwang, W., Jo, A., Hwang, G.-H., Jung, M., Kim, U. G., Cui, G., Kim, H. S., Eom, J.-H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601900
Breton, C. A., Clark, P., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · Figshare · doi:10.6084/m9.figshare.11999370
Breton, C. A., Clark, P. M., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · Figshare · doi:10.6084/m9.figshare.11999367
Breton, C. A., Clark, P., Wang, L., Greig, J. A., & Wilson, J. M. (2020) · Figshare · doi:10.6084/m9.figshare.11999373
Kwon, J., Kim, M., Hwang, W., Jo, A., Hwang, G.-H., Jung, M., Kim, U. G., Cui, G., Kim, H. S., Eom, J.-H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601891
Kwon, J., Kim, M., Hwang, W., Jo, A., Hwang, G.-H., Jung, M., Kim, U. G., Cui, G., Kim, H. S., Eom, J.-H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601906
Kwon, J., Kim, M., Hwang, W. C., Jo, A., Hwang, G.-H., Jung, M., Kim, U. G., Cui, G., Kim, H. S., Eom, J.-H., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22601897
Nanocarriers for the delivery of the CRISPR/Cas9 system
Hwang, S., Ko, H., Lee, H.-Y., & Choi, J. H. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2598332 · Cited by 1
3-D Genome organization of DNA damage repair
Banerjee, U. K. (2017) · theses.fr (ABES) · doi:10.70675/25480b49zc194z4a4bzb6b0z2f84dab6ccef
A genetic dissection of human ILC development and plasticity
Croft, C. A. (2021) · theses.fr (ABES) · doi:10.70675/73858fbbz7a53z457fz91ecz36b3626efecf
Ex vivo gene therapy for β-hemoglobinpathies and metabolic disorders
Laurent, M. (2023) · theses.fr (ABES) · doi:10.70675/ba5c585dzaa79z48d2z9f40zfee1cdd49d32
Toishigawa, K., Magoori, K., Sato, H., Edahiro, T., Ureshino, H., Shindo, T., Suzuki, R., Sakuma, T., Yamamoto, T., Okada, M., et al. (2026) · Cytotherapy · doi:10.1016/j.jcyt.2026.102911
Bakhtiyari, N., Masoudi‐Sobhanzadeh, Y., Farajnia, S., & Kumar, S. (2026) · Bioinformatics · doi:10.1093/bioinformatics/btag483
Metadata
- Authors
- Wang, X., Wang, Y., Wu, X., Wang, J., Wang, Y., Qiu, Z., Chang, T., Huang, H., Lin, R.-J., & Yee, J.-K.
- Affiliations
- City Of Hope National Medical Center (US)
- First Affiliated Hospital Zhejiang University (CN)
- Corresponding author
- Yee, Jiing-Kuan
- Venue
- Nature Biotechnology
- Published
- 2015-01-19
- Volume
- 33
- Issue
- 2
- Pages
- 175-178
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2051255304
- Cited by
- 442
- References
- 20
- Citations by year
- 2026: 5 · 2025: 17 · 2024: 18 · 2023: 25 · 2022: 31 · 2021: 38 · 2020: 47 · 2019: 36 · 2018: 46 · 2017: 57 · 2016: 70 · 2015: 52
- FWCI
- 32.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- off-target cleavage, CRISPR/Cas9, TALEN, integrase-defective lentiviral vectors, genome editing, single guide RNA design, mismatch tolerance
- MeSH terms
- Genetic Vectors, Humans, Genome, Human, Lentivirus, RNA Editing, Integrases, HEK293 Cells, High-Throughput Nucleotide Sequencing, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review